Uncategorized
Sun Pharma completes tender offer for InSite Vision
Thea Acquisition Corp., an indirect wholly owned subsidiary of Sun Pharma, has completed the cash tender offer for all outstanding shares of InSite Vision’s common stock, Sun Pharma announced in a press release. InSite’s outstanding shares of common stock expired on Oct. 27.